221 related articles for article (PubMed ID: 21270985)
1. Cleavable β-cyclodextrin nanocapsules incorporating Gd(III)-chelates as bioresponsive MRI probes.
Martinelli J; Fekete M; Tei L; Botta M
Chem Commun (Camb); 2011 Mar; 47(11):3144-6. PubMed ID: 21270985
[TBL] [Abstract][Full Text] [Related]
2. Tris(pyrone) chelates of Gd(III) as high solubility MRI-CA.
Puerta DT; Botta M; Jocher CJ; Werner EJ; Avedano S; Raymond KN; Cohen SM
J Am Chem Soc; 2006 Feb; 128(7):2222-3. PubMed ID: 16478170
[TBL] [Abstract][Full Text] [Related]
3. Poly-beta-cyclodextrin based platform for pH mapping via a ratiometric 19F/1H MRI method.
Gianolio E; Napolitano R; Fedeli F; Arena F; Aime S
Chem Commun (Camb); 2009 Oct; (40):6044-6. PubMed ID: 19809638
[TBL] [Abstract][Full Text] [Related]
4. Protein-targeted gadolinium-based magnetic resonance imaging (MRI) contrast agents: design and mechanism of action.
Caravan P
Acc Chem Res; 2009 Jul; 42(7):851-62. PubMed ID: 19222207
[TBL] [Abstract][Full Text] [Related]
5. High-relaxivity magnetic resonance imaging (MRI) contrast agent based on supramolecular assembly between a gadolinium chelate, a modified dextran, and poly-beta-cyclodextrin.
Battistini E; Gianolio E; Gref R; Couvreur P; Fuzerova S; Othman M; Aime S; Badet B; Durand P
Chemistry; 2008; 14(15):4551-61. PubMed ID: 18386282
[TBL] [Abstract][Full Text] [Related]
6. GdIII complexes with fast water exchange and high thermodynamic stability: potential building blocks for high-relaxivity MRI contrast agents.
Laus S; Ruloff R; Tóth E; Merbach AE
Chemistry; 2003 Aug; 9(15):3555-66. PubMed ID: 12898682
[TBL] [Abstract][Full Text] [Related]
7. A beta-cyclodextrin "click cluster" decorated with seven paramagnetic chelates containing two water exchange sites.
Bryson JM; Chu WJ; Lee JH; Reineke TM
Bioconjug Chem; 2008 Aug; 19(8):1505-9. PubMed ID: 18620446
[TBL] [Abstract][Full Text] [Related]
8. New paramagnetic supramolecular adducts for MRI applications based on non-covalent interactions between Gd(III)-complexes and beta- or gamma-cyclodextrin units anchored to chitosan.
Aime S; Gianolio E; Uggeri F; Tagliapietra S; Barge A; Cravotto G
J Inorg Biochem; 2006 May; 100(5-6):931-8. PubMed ID: 16412512
[TBL] [Abstract][Full Text] [Related]
9. AAZTA-based bifunctional chelating agents for the synthesis of multimeric/dendrimeric MRI contrast agents.
Gugliotta G; Botta M; Tei L
Org Biomol Chem; 2010 Oct; 8(20):4569-74. PubMed ID: 20740241
[TBL] [Abstract][Full Text] [Related]
10. Dendrimeric β-cyclodextrin/Gd(III) chelate supramolecular host-guest adducts as high-relaxivity MRI probes.
Martinelli J; Thangavel K; Tei L; Botta M
Chemistry; 2014 Aug; 20(35):10944-52. PubMed ID: 24827137
[TBL] [Abstract][Full Text] [Related]
11. High-relaxivity MRI contrast agents: where coordination chemistry meets medical imaging.
Werner EJ; Datta A; Jocher CJ; Raymond KN
Angew Chem Int Ed Engl; 2008; 47(45):8568-80. PubMed ID: 18825758
[TBL] [Abstract][Full Text] [Related]
12. Gadolinium(III) 1,2-hydroxypyridonate-based complexes: toward MRI contrast agents of high relaxivity.
Xu J; Churchill DG; Botta M; Raymond KN
Inorg Chem; 2004 Sep; 43(18):5492-4. PubMed ID: 15332797
[TBL] [Abstract][Full Text] [Related]
13. The gadolinium(III)-water hydrogen distance in MRI contrast agents.
Caravan P; Astashkin AV; Raitsimring AM
Inorg Chem; 2003 Jun; 42(13):3972-4. PubMed ID: 12817950
[TBL] [Abstract][Full Text] [Related]
14. A chemical strategy for the relaxivity enhancement of Gd(III) chelates anchored on mesoporous silica nanoparticles.
Carniato F; Tei L; Cossi M; Marchese L; Botta M
Chemistry; 2010 Sep; 16(35):10727-34. PubMed ID: 20669190
[TBL] [Abstract][Full Text] [Related]
15. Comparison of a tartaric acid derived polymeric MRI contrast agent to a small molecule model chelate.
Lucas RL; Benjamin M; Reineke TM
Bioconjug Chem; 2008 Jan; 19(1):24-7. PubMed ID: 18092744
[TBL] [Abstract][Full Text] [Related]
16. A novel cholic acid-based contrast enhancement agent for targeted MRI.
Chong HS; Song HA; Lim S; Macrenaris K; Ma X; Lee H; Bui P; Meade T
Bioorg Med Chem Lett; 2008 Apr; 18(7):2505-8. PubMed ID: 18337094
[TBL] [Abstract][Full Text] [Related]
17. A Gd3+-based magnetic resonance imaging contrast agent sensitive to beta-galactosidase activity utilizing a receptor-induced magnetization enhancement (RIME) phenomenon.
Hanaoka K; Kikuchi K; Terai T; Komatsu T; Nagano T
Chemistry; 2008; 14(3):987-95. PubMed ID: 17992679
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of relaxivity rates of Gd-DTPA complexes by intercalation into layered double hydroxide nanoparticles.
Xu ZP; Kurniawan ND; Bartlett PF; Lu GQ
Chemistry; 2007; 13(10):2824-30. PubMed ID: 17186555
[TBL] [Abstract][Full Text] [Related]
19. Environment-sensitive and enzyme-sensitive MR contrast agents.
Querol M; Bogdanov A
Handb Exp Pharmacol; 2008; (185 Pt 2):37-57. PubMed ID: 18626598
[TBL] [Abstract][Full Text] [Related]
20. Brain tumor enhancement in magnetic resonance imaging at 3 tesla: intraindividual comparison of two high relaxivity macromolecular contrast media with a standard extracellular gd-chelate in a rat brain tumor model.
Fries P; Runge VM; Bücker A; Schürholz H; Reith W; Robert P; Jackson C; Lanz T; Schneider G
Invest Radiol; 2009 Apr; 44(4):200-6. PubMed ID: 19300099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
